| Lastest Insider Transactions Of JOHNSON & JOHNSON ( JNJ ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| JNJ | JOHNSON & JOHNSON | REED JOHN C | EVP, Innovative Medicine, R&D | 2024-05-01 | Option Exercise | 22,255 | 0.00 | 0 | 2024-05-03 16:31:19 |
| JNJ | JOHNSON & JOHNSON | Broadhurst Vanessa | EVP, Global Corp Affairs | 2024-03-13 | Sell | 8,891 | 162.16 | 1,441,765 | 2024-03-13 16:36:32 |
| JNJ | JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief TO and Risk Officer | 2024-02-13 | Option Exercise | 651 | 0.00 | 0 | 2024-02-15 16:53:53 |
| JNJ | JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | 2024-02-13 | Option Exercise | 1,780 | 0.00 | 0 | 2024-02-15 16:53:51 |
| JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WWC. Innovative Medicine | 2024-02-13 | Option Exercise | 1,302 | 0.00 | 0 | 2024-02-15 16:53:44 |
| JNJ | JOHNSON & JOHNSON | Swanson James D. | EVP, CIO | 2024-02-13 | Option Exercise | 447 | 0.00 | 0 | 2024-02-15 16:53:40 |
| JNJ | JOHNSON & JOHNSON | Schmid Timothy | EVP, WW Chair, MedTech | 2024-02-13 | Option Exercise | 499 | 0.00 | 0 | 2024-02-15 16:53:35 |
| JNJ | JOHNSON & JOHNSON | Fasolo Peter | Exec VP, Chief HR Officer | 2024-02-13 | Option Exercise | 925 | 0.00 | 0 | 2024-02-15 16:53:34 |
| JNJ | JOHNSON & JOHNSON | Hait William | See Remarks | 2024-02-13 | Option Exercise | 834 | 0.00 | 0 | 2024-02-15 16:53:33 |
| JNJ | JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board | 2024-02-13 | Option Exercise | 3,470 | 0.00 | 0 | 2024-02-15 16:53:32 |
| JNJ | JOHNSON & JOHNSON | Broadhurst Vanessa | EVP, Global Corp Affairs | 2024-02-13 | Option Exercise | 408 | 0.00 | 0 | 2024-02-15 16:53:23 |
| JNJ | JOHNSON & JOHNSON | Forminard Elizabeth | Executive VP, General Counsel | 2024-02-13 | Option Exercise | 651 | 0.00 | 0 | 2024-02-15 16:53:23 |
| JNJ | JOHNSON & JOHNSON | Decker Robert J | VP Corporate Controller | 2024-02-13 | Option Exercise | 313 | 0.00 | 0 | 2024-02-15 16:53:07 |
| JNJ | JOHNSON & JOHNSON | Broadhurst Vanessa | EVP, Global Corp Affairs | 2024-02-12 | Option Exercise | 4,701 | 0.00 | 0 | 2024-02-14 18:36:50 |
| JNJ | JOHNSON & JOHNSON | Hait William | See Remarks | 2024-02-12 | Option Exercise | 8,932 | 0.00 | 0 | 2024-02-14 18:36:47 |
| JNJ | JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | 2024-02-12 | Option Exercise | 25,835 | 0.00 | 0 | 2024-02-14 18:36:45 |
| JNJ | JOHNSON & JOHNSON | Forminard Elizabeth | Executive VP, General Counsel | 2024-02-12 | Option Exercise | 2,859 | 0.00 | 0 | 2024-02-14 18:36:41 |
| JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WWC. Innovative Medicine | 2024-02-12 | Option Exercise | 26,202 | 0.00 | 0 | 2024-02-14 18:36:31 |
| JNJ | JOHNSON & JOHNSON | Fasolo Peter | Exec VP, Chief HR Officer | 2024-02-12 | Option Exercise | 14,960 | 0.00 | 0 | 2024-02-14 18:36:25 |
| JNJ | JOHNSON & JOHNSON | Swanson James D. | EVP, CIO | 2024-02-12 | Option Exercise | 5,456 | 0.00 | 0 | 2024-02-14 18:36:22 |
| JNJ | JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board | 2024-02-12 | Option Exercise | 36,618 | 0.00 | 0 | 2024-02-14 18:36:19 |
| JNJ | JOHNSON & JOHNSON | Schmid Timothy | EVP, WW Chair, MedTech | 2024-02-12 | Option Exercise | 5,736 | 0.00 | 0 | 2024-02-14 18:36:17 |
| JNJ | JOHNSON & JOHNSON | Decker Robert J | VP Corporate Controller | 2024-02-12 | Option Exercise | 1,912 | 0.00 | 0 | 2024-02-14 18:36:13 |
| JNJ | JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief TO and Risk Officer | 2024-02-12 | Option Exercise | 13,813 | 0.00 | 0 | 2024-02-14 18:36:08 |
| JNJ | JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board | 2024-02-09 | Option Exercise | 130,969 | 90.44 | 11,844,836 | 2024-02-13 17:18:25 |
| JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | 2024-02-08 | Sell | 59,397 | 156.27 | 9,281,969 | 2024-02-12 19:25:22 |
| JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | 2024-02-08 | Option Exercise | 63,136 | 85.08 | 5,371,865 | 2024-02-12 19:25:22 |
| JNJ | JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board | 2024-02-08 | Option Exercise | 5,225 | 0.00 | 0 | 2024-02-12 19:25:15 |
| JNJ | JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief TO and Risk Officer | 2024-02-08 | Option Exercise | 1,971 | 0.00 | 0 | 2024-02-12 19:25:14 |
| JNJ | JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | 2024-02-08 | Option Exercise | 3,686 | 0.00 | 0 | 2024-02-12 19:25:10 |
| JNJ | JOHNSON & JOHNSON | Forminard Elizabeth | Executive VP, General Counsel | 2024-02-08 | Option Exercise | 979 | 0.00 | 0 | 2024-02-12 19:24:59 |
| JNJ | JOHNSON & JOHNSON | Swanson James D. | See Remarks | 2024-02-08 | Option Exercise | 1,868 | 0.00 | 0 | 2024-02-12 19:24:57 |
| JNJ | JOHNSON & JOHNSON | Schmid Timothy | EVP, WW Chair, MedTech | 2024-02-08 | Option Exercise | 1,964 | 0.00 | 0 | 2024-02-12 19:24:45 |
| JNJ | JOHNSON & JOHNSON | Fasolo Peter | Exec VP, Chief HR Officer | 2024-02-08 | Option Exercise | 2,135 | 0.00 | 0 | 2024-02-12 19:24:38 |
| JNJ | JOHNSON & JOHNSON | Hait William | See Remarks | 2024-02-08 | Option Exercise | 3,059 | 0.00 | 0 | 2024-02-12 19:24:31 |
| JNJ | JOHNSON & JOHNSON | Broadhurst Vanessa | EVP, Global Corp Affairs | 2024-02-08 | Option Exercise | 1,880 | 0.00 | 0 | 2024-02-12 19:24:24 |
| JNJ | JOHNSON & JOHNSON | Decker Robert J | VP Corporate Controller | 2024-02-08 | Option Exercise | 655 | 0.00 | 0 | 2024-02-12 19:24:16 |
| JNJ | JOHNSON & JOHNSON | Fasolo Peter | Exec VP, Chief HR Officer | 2023-07-25 | Sell | 20,000 | 170.32 | 3,406,498 | 2023-07-27 17:52:58 |
| JNJ | JOHNSON & JOHNSON | Hait William | See Remarks | 2023-07-26 | Sell | 14,698 | 172.00 | 2,528,056 | 2023-07-27 17:52:57 |
| JNJ | JOHNSON & JOHNSON | Hait William | See Remarks | 2023-07-26 | Option Exercise | 14,698 | 90.44 | 1,329,287 | 2023-07-27 17:52:57 |
| JNJ | JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief TO and Risk Officer | 2023-06-12 | Sell | 12,465 | 160.00 | 1,994,400 | 2023-06-14 16:19:45 |
| JNJ | JOHNSON & JOHNSON | Swanson James D. | See Remarks | 2023-03-06 | Sell | 1,061 | 154.76 | 164,199 | 2023-03-08 16:16:29 |
| JNJ | JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board | 2023-02-10 | Option Exercise | 5,220 | 0.00 | 0 | 2023-02-14 16:37:16 |
| JNJ | JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief TO and Risk Officer | 2023-02-10 | Option Exercise | 1,807 | 0.00 | 0 | 2023-02-14 16:37:04 |
| JNJ | JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | 2023-02-10 | Option Exercise | 3,449 | 0.00 | 0 | 2023-02-14 16:36:25 |
| JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | 2023-02-10 | Option Exercise | 3,570 | 0.00 | 0 | 2023-02-14 16:36:18 |
| JNJ | JOHNSON & JOHNSON | McEvoy Ashley | EVP, WW Chair, MedTech | 2023-02-10 | Option Exercise | 2,999 | 0.00 | 0 | 2023-02-14 16:36:06 |
| JNJ | JOHNSON & JOHNSON | Hait William | See Remarks | 2023-02-10 | Option Exercise | 3,856 | 0.00 | 0 | 2023-02-14 16:35:39 |
| JNJ | JOHNSON & JOHNSON | Mongon Thibaut | Exec VP, WW Chair, Cons Health | 2023-02-10 | Option Exercise | 2,285 | 0.00 | 0 | 2023-02-14 16:35:37 |
| JNJ | JOHNSON & JOHNSON | Decker Robert J | VP Corporate Controller | 2023-02-10 | Option Exercise | 581 | 0.00 | 0 | 2023-02-14 16:35:30 |
| JNJ | JOHNSON & JOHNSON | Broadhurst Vanessa | EVP, Global Corp Affairs | 2023-02-10 | Option Exercise | 1,592 | 0.00 | 0 | 2023-02-14 16:35:07 |
| JNJ | JOHNSON & JOHNSON | Fasolo Peter | Exec VP, Chief HR Officer | 2023-02-10 | Option Exercise | 2,078 | 0.00 | 0 | 2023-02-14 16:35:02 |
| JNJ | JOHNSON & JOHNSON | Swanson James D. | See Remarks | 2022-02-14 | Option Exercise | 1,291 | 0.00 | 0 | 2023-02-14 16:34:39 |
| JNJ | JOHNSON & JOHNSON | Swanson James D. | See Remarks | 2022-02-14 | Option Exercise | 1,291 | 0.00 | 0 | 2023-02-14 16:34:39 |
| JNJ | JOHNSON & JOHNSON | Gorsky Alex | Directior | 2023-01-17 | Option Exercise | 547,692 | 72.54 | 39,729,576 | 2023-01-18 16:39:45 |
| JNJ | JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board | 2023-01-17 | Option Exercise | 148,538 | 72.54 | 10,774,947 | 2023-01-18 16:39:41 |
| JNJ | JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | 2022-12-13 | Sell | 14,781 | 179.60 | 2,654,661 | 2022-12-15 16:34:45 |
| JNJ | JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | 2022-12-13 | Option Exercise | 14,781 | 88.19 | 1,303,589 | 2022-12-15 16:34:45 |
